North-east area of France was hit in February 2020 by the new coronavirus disease, moreseverely than other French regions. Factors affecting the evolution of the disease andits severity have been quickly identified, among them figuring different kinds of immunedeficiency. Even if nowadays HIV infection is usually well controlled by ARV drugs, thosepatients with uncontrolled viral load and/or low CD4 cell counts, remain at higher riskof severe COVID infection. In this context, the primary objective of our study is aimedat evaluating the prevalence of SARS-CoV-2 antibodies in a cohort of HIV-infectedpatients followed-up in an HIV-infection care center. Secondary objectives are:evaluating whether the antibodies are protective or not, the kinetic of these antibodies,and HIV associated factors with the presence of antibodies.
Other: Blood Sample
Blood Sample
Inclusion Criteria:
- adults (> 18 years)
- HIV-infected patients
- subjects with social insurance
- subjects able to understand study purposes, and to give a written and informed
consent
Exclusion Criteria :
- subjects unable to understand informations on the study, and to provide informed
consent
- subjects under guardianship or curatorship
- subjects under judicial protection
Hôpitaux Universitaires de Strasbourg
Strasbourg, France